Ranbaxy sets out to conquer global markets

By SiliconIndia   |   Wednesday, 22 October 2003, 07:00 Hrs
Printer Print Email Email
KOLKATA: To leverage its strength in the global antibiotic markets, Indian pharmaceutical giant, Ranbaxy Laboratory Limited is now betting big on the revolutionary OD (once-a-day dosage) antibiotic formulations.

The company is planning to go global with this niche segment and has lined up a strategy for phased launch of these formulations and future growth.

The formulations that are being considered for launch by Ranbaxy in different markets across the world are its three blockbuster OD formulations in the domestic market --- ciprofloxacin OD (Cifran OD), ofloxacin OD (Zanocin OD) and clarithromycin OD (Crixan OD).

For starters, Ranbaxy has planned launch of the OD antibiotic formulations under its own brand in markets where it already has strong presence like China, Brazil, Myanmar, and Cambodia.




SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..